Skip to main content
PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
41.96
+2.60 (6.61%)
Nov 20, 2024, 4:00 PM EST - Market closed

PTC Therapeutics Revenue

PTC Therapeutics had revenue of $196.79M in the quarter ending September 30, 2024, with 0.11% growth. This brings the company's revenue in the last twelve months to $900.66M, up 12.84% year-over-year. In the year 2023, PTC Therapeutics had annual revenue of $937.82M with 34.20% growth.

Revenue (ttm)
$900.66M
Revenue Growth
+12.84%
P/S Ratio
3.56
Revenue / Employee
$853,710
Employees
1,055
Market Cap
3.24B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023937.82M239.02M34.20%
Dec 31, 2022698.80M160.21M29.75%
Dec 31, 2021538.59M157.83M41.45%
Dec 31, 2020380.77M73.79M24.04%
Dec 31, 2019306.98M42.25M15.96%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BrightSpring Health Services 10.59B
Envista Holdings 2.50B
Neogen 912.20M
Apellis Pharmaceuticals 715.22M
HUTCHMED (China) 610.81M
Agios Pharmaceuticals 32.87M
ImmunityBio 7.33M
Verona Pharma 5.62M
Revenue Rankings

PTCT News

More News